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Summary 
Research on the detection of enterobacteria of antibiotic resistance markers in the current 
context of rapid increase in the prevalence of resistant strains of E. coli, the need to use methods 
of molecular biology is becoming increasingly stringent, which is far more sensitive than 
phenotypic testing and surveillance and epidemiological monitoring of strains producing CTX-M 
are important in determining treatment tactics for review empirical treatment protocols. Our 
study is something new for our country by molecular analysis of plasmid genes with great 
potential for the communities. 
 
Rezumat  
Actualităţi privind rezistenţa la antibiotice a E. coli izolată de la  
pacienţii cu infecţii ale tractului urinar 
 În contextul actual de creştere rapidă a prevalenţei rezistenţei tulpinilor de E. coli 
necesitatea utilizării metodelor de biologie moleculară devine din ce în ce mai stringentă, acestea 
fiind metode mult mai sensibile decât testarea fenotipică, iar supravegherea şi monitorizarea 
epidemiologică a tulpinilor producătoare de CTX-M sunt importante în stabilirea tacticilor 
terapeutice pentru revizuirea protocoalelor de tratament empiric. Studiu efectuat de noi 
reprezintă ceva nou pentru republica noastră prin analiza moleculară a unor gene plasmidice cu 
mare potenţial de diseminare în colectivităţi.               
 
Introduction 
Antimicrobial resistance has become an important problem worldwide. Bacterial 
resistance to antimicrobial agents has been emerging and rapidly disseminating among many 
nosocomial and community-acquired pathogens [1,4 ].   
 Infections caused by resistant microorganisms determine a high morbidity and mortality 
level due to therapeutic failures and rising costs for medical care [1,14 ].  
The main causes of increasing resistance to antibiotics are inappropriate use and invalid 
prescription of these preparations by misinterpretation of symptoms, uncertain diagnosis and 
perceived expectations of the patient, duration too long / too short or inappropriate dose 
administration, self-medication, use of antibiotics in the veterinary sector, poor arsenal of 
diagnostic measures, medicaments and vaccines, inadequate supervision and control over 
medicaments use [4, 8]. 
Difficulties in treatment of infectious diseases occur more often in infections caused by 
producing strains of ESBLs (Extended Spectrum Beta Lactamases) - enzymes that develop 
resistance to extended-spectrum antibiotics [15]. 
The emergence of strains of Enterobacteriaceae producer of ESBLs is at present days a 
strong threat, in terms of effectiveness of antibiotics use in therapy of infections [9]. 
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E. coli, the most common member of the family Enterobacteriaceae accounts for 75-90 
% of all urinary tract infections in both patients and out patients  
Uropathogenic E. coli are the primary causes of community-acquired UTIs with an 
estimated 20% of women over the age of 18 years suffering from at least one UTI in their life 
time [1 ]. 
Characteristics and dimensions of the phenomenon of antibiotic resistance were identified 
by laboratory methods and demonstrated by unfavorable clinical evolution of patients [6, 11, 13]. 
Analyzing the literature data we highlight a number of specialized phenotypic and 
genotypic methods for to determine the secretors strains of ESBLs [15, 16]. 
 The specific type of beta-lactamase is not possible to be detected by routine tests (disc - 
diffusion, chromogenic tests etc.) Combination of several types of beta-lactamases in the same 
microorganism makes it more difficult to detect correctly. Studies made by other researchers 
demonstrate the importance of molecular biology techniques in detecting of ESBLs [2, 7, 12]. 
Correct detection of ESBLs producing strains, CTX-M remains a challenge for the 
microbiology laboratory and is very important to prevent clinical failure due to inadequate 
antibiotic therapy. 
The purpose of the proposed study was to identify phenotypes of resistance among 
circulating strains of E. coli in our geographical area and determining the molecular mechanism 
of resistance prove, by detecting the presence of resistance markers (beta-lactamase) using 
phenotypic and molecular methods. 
 
Material and methods 
For the study were collected 118 urine and stool samples from people with a diagnosis of 
urinary tract infection (UTI). The study was organized under the Scientific Research Institute of 
Mother and Child Health Care, Diagnostic Center "Modus Vivendi". Researches were conducted 
in the laboratory of Center epidemiology of the highly contagious disease and Biosafety National 
Center for Public Health, in collaboration with the bacteriology laboratory of the hospital Bichat 
- Claude Bernard, Paris, France. 
Urine samples were sown on media differential diagnoses: Endo, blood agar, hypersaline 
agar with egg, enterococci agar, Mueller Hinton, Sabouraud. For the research were selected only 
strains isolated from urine significantly positive (≥ 10
5
 CFU / ml). Strains of E. coli were 
identified by gender and / or species by conventional biochemical tests (Voges  - Proskauer test, 
indole test, urea, citrate, fenilalanindezaminaze etc.). Confirmatory tests were performed using 
API 20E galleries (BioMérieux, France). Subsequent phase of the research included the 
susceptibility testing of E. coli strains to antimicrobial preparations using phenotypic methods 
(Kirby-Bauer disk diffusion test, synergy test - bidimensional distribution of the two discs with 
antibiotics) and molecular biology (polymerase chain reaction , sequencing, multiplex PCR, Rep 
- PCR). 
Evaluation of the results was performed in accordance with recommendations of Clinical 
and Laboratory Standards Institute guidelines (CLSI M100-S20, 2010). 
Strain of E. coli ATCC 25922 was used as a reference strain for antibiotic susceptibility 
testing on culture media used. 
Susceptibility testing of E. coli strains to antimicrobial preparations included the 
following classes of antibiotics: beta-lactam antibiotics - amoxicillin (AMX), ticarcillin (TIC), 
amoxicillin / clavulanate (AMC), cefotaxime (CTX), ceftazidime (CFT), ceftoxitin ( FOX), 
cefepim (CFP), ertapenem (ETP), aminoglycosides - gentamicin (GM), amikacin (AN), 
kanamycin (K); fluorchinolone - nalidixic acid (NA), ofloxacin (OFX), ciprofloxacin (CIP), 





Results and discussions 
Microbial resistance to antibiotics is a global public health problem is largely due to 
inappropriate use of antibiotics. Phenomenon of antibiotic resistance in Europe is in continuous 
growth. The urinary tract infections (UTI), refers to the infectious diseases commonly 
encountered in medical practice which record a high incidence and prevalence with medical and 
economic consequences. Strains involved in the etiology of UTI are part of the epidemiological 
and bacteriological studies in recent years [3, 14]. 
The results of studies show that E. coli, germs that represent a normal microflora of the 
gastrointestinal tract under certain conditions becomes a significant resistance to antibacterial 
preparations and can cause intestinal and extraintestinal infections (including urinary) [5, 15,]. 
According to studies concerning the prevalence and etiological structure of urinary 
infections in 95% of cases are caused by agents of the family Enterobacteriaceae (of which 80-
95% of cases E. coli, rarer Proteus spp. or Klebsiella spp.) and the rest about 5% Pseudomonas 
aeruginosa, staphylococci, yeasts of the genus Candida, etc. [8, 10, 15, 16]. 
The results of biochemical screening tests and confirmation of Enterobacteriaceae, 
revealed that from all the strains isolated from patients with UTI, were predominant strains of E. 
coli (92.9%). 
E. coli strains isolated from patients with UTI were tested to identify the degree of 
resistance to five classes of antibiotics. Resistance to antibiotics determined by the method of 
Kirby-Bauer disk diffusion revealed that studied E. coli strains, isolated from people with ITU 
has a high level of resistance, including antibacterial preparations beta - lactam. Also beta-
diffusion method does not provide sufficient data to assess the level of resistance and correct 
monitoring of antibacterial therapy. Were used synergy tests which could elucidate one of the 
mechanisms of antibiotic resistance of E. coli strains - the presence of beta - lactamases. This test 
uses a beta-lactamase inhibitor, clavulanic acid usually in combination with an oximino-
cephalosporin such as ceftazidime, cefotaxime, ceftriaxone. The antibiotic discs were placed in 
such a way, that you can view images of synergy between discs with amoxicillin / clavulanic 
acid and the cephalosporin III generation (CG3). Sequence location of the discs with appropriate 
antibiotics was following: TIC - FOX - CFP - AMX - GM-CFT - AMC - CTX. 
As a result, we determined that of 118 E.coli strains isolated from urine cultures, 91 
strains of E. coli have resistance to the ticarcillin, 49 strains – to the amoxicillin, 26 strains - to 
the cotrimoxazole, each 21 strains – to the nalidixic acid and ofloxacin, 18 strains - to the 
ciprofloxacin and 7 strains of E. coli to other antibiotics (Fig. 1). 
E. coli strains producing of beta-lactamase were preserved in an environment containing 
ox-heart broth and 10% of glycerol and then were stored by freezing at - 80°C to be further 
tested by molecular biology techniques. 
Conduct adequate treatment requires rapid and accurate identification of antibiotic 
resistant strains using molecular biology techniques. 
Determination of the resistance profiling data showed that those strains have resistance to 
the following groups of antibiotics: aminoglycosides - gentamicin (72%), fluoroquinolone - 
nalidixic acid (89%) and sulphonamides - cotrimoxazole (72%). Strains isolated from the stool 
are also polyresistant. They are resistant to the same classes of antimicrobial preparations as E. 
coli ESBLs isolated from urine: 53% to the aminoglycosides (gentamicin), 56% to the 















































































Figure 1. Profile of resistance of E. coli strains 
  
E. coli ESBLs strains isolated from urine samples were of CTX-M type, namely: a strain 
of type CTX-M-1, 3 strains of type CTX-M-14, other 3 strains are of CTX -M-15 type. E. coli 
ESBLs strains found in stool samples were predominantly of CTX type and only one enzyme of 
SHV type. In contradistinction to urinary strains those were relatively more varied and namely a 
strain - CTX-M-1, 2 strains - CTX-M-3, 8 strains - CTX-M-14 and 3 strains - CTX-M-15. 
The ability to clone of E. coli ESBLs strains detected in urine and stool was investigated 
by Rep-PCR method, only four strains of E. coli contain ESBLs in both urine and feces (U + / F 
+). At three of four of E. coli strains ESBLs U + / F + tested, was present Rep-PCR similar 
profile. 
Determining phylogenetic group of urinary strains was found that 58,5% of E. coli 
ESBLs strains are from group B2, 27,9% - group A, 12,7% - group D and 0,9 from other groups. 
The strains detected in the faeces have following phylogenetic diversity: 53.4% - group A, 
23,1% - group B2 and group D, and 0,4 - other groups (Figure 2). 
Figure 2. Phylogenetic groups of E. coli ESBLs strains 
 
Phenotypic and genotypic monitoring of antibiotic resistance markers in the human 
population is a constitutive key in the national surveillance system for antimicrobial resistance 





































E.coli ESBLs strains detected in the faeces 
   





1. Molecular biology methods involved relatively high costs, but provided reproducible results in 
a very short time, detecting in E. coli strains isolated from urine and coprocultures ESBLs – 
beta-lactam antibiotics resistance marker.  
2. The movement of E. coli strains secretors of ESBLs of the CTX-M type within Republic of 
Moldova demonstrates the complexity of mechanisms of resistance. 
3. It is hereby recommended that in view of the resistance rates to antimicrobial agents used in 
UTI therapy, antimicrobial agent usage policies, especially empirical therapies, should be 
based on antimicrobial resistance surveillance studies. 
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